AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 64 filers reported holding AVROBIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $15,000 | -65.9% | 11,429 | +0.3% | 0.00% | – |
| Q4 2021 | $44,000 | -58.1% | 11,390 | -39.5% | 0.00% | – |
| Q3 2021 | $105,000 | -30.5% | 18,824 | +10.9% | 0.00% | – |
| Q2 2021 | $151,000 | -94.8% | 16,979 | -88.1% | 0.00% | -100.0% |
| Q4 2019 | $2,881,000 | +42.6% | 143,119 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,021,000 | -16.3% | 143,119 | -3.7% | 0.00% | 0.0% |
| Q2 2019 | $2,416,000 | -23.4% | 148,617 | +3.8% | 0.00% | 0.0% |
| Q1 2019 | $3,155,000 | +32.2% | 143,111 | -0.2% | 0.00% | 0.0% |
| Q4 2018 | $2,387,000 | -68.1% | 143,328 | -0.6% | 0.00% | -50.0% |
| Q3 2018 | $7,479,000 | +73.0% | 144,185 | -4.8% | 0.00% | +100.0% |
| Q2 2018 | $4,324,000 | – | 151,382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |